Valuation : Haleon plc

Market Cap 30.24B 40.96B 35.22B 33.13B 56.56B 3,873B 56.74B 393B 152B 1,984B 154B 150B 6,318B P/E 2026 *
17.9x
P/E 2027 * 15.8x
Enterprise Value 37.12B 50.27B 43.23B 40.66B 69.42B 4,754B 69.64B 482B 186B 2,435B 189B 185B 7,755B EV / Sales 2026 *
3.26x
EV / Sales 2027 * 3.08x
Free-Float
98.46%
Yield 2026 *
2.35%
Yield 2027 * 2.6%

Last Transcript : Haleon plc

1 day-0.15%
1 week-7.25%
Current month-6.82%
1 month-6.05%
3 months+3.66%
6 months-8.24%
Current year-8.46%
1 week 341.3
Extreme 341.3
370.3
1 month 341.3
Extreme 341.3
374.6
Current year 317.8
Extreme 317.8
416.1
1 year 274.4
Extreme 274.4
416.1
3 years 274.4
Extreme 274.4
419.5
5 years 241.17
Extreme 241.1735
419.5
10 years 241.17
Extreme 241.1735
419.5
Manager TitleAgeSince
Chief Executive Officer 59 2021-07-21
Director of Finance/CFO 58 2024-10-31
Chief Tech/Sci/R&D Officer 63 2025-07-31
Director TitleAgeSince
Director/Board Member 59 2022-05-22
Chairman 71 2025-12-31
Director/Board Member 59 2022-07-17
Date Insider Type Main position Quantity % Market Cap. Importance
6/30/26 Free

Chief Financial Officer

283,193 0.0032%
6/30/26 Tax

Chief Financial Officer

-133,301 0.0015%
5/19/26 Others 4,415 0.0000% -
Change 5-day change 1-year change 3-year change Capi.($)
-0.12%-7.25%-4.43%+7.61% 40.96B
-0.88%-0.64%+58.05%+100.51% 1,024B
-1.15%+3.53%+54.25%+71.99% 663B
-1.44%+0.02%+20.65%+72.22% 453B
-0.23%+1.38%+30.43%+37.24% 349B
-8.99%-12.87%+11.51%+29.48% 295B
-0.75%+0.10%+0.03%+10.40% 253B
-1.55%+1.71%+54.15%+71.87% 236B
-0.89%+0.85%-14.57%-56.26% 206B
-0.15%+3.18%+31.24%+104.21% 187B
Average -1.46%+0.38%+24.13%+44.93% 370.83B
Weighted average by Cap. -1.33%+0.44%+36.22%+62.84%

Financials

2026 *2027 *
Net sales 11.39B 15.42B 13.26B 12.48B 21.3B 1,459B 21.37B 148B 57.18B 747B 57.92B 56.66B 2,379B 11.86B 16.07B 13.82B 13B 22.19B 1,520B 22.26B 154B 59.57B 778B 60.35B 59.03B 2,479B
Net income 1.69B 2.3B 1.97B 1.86B 3.17B 217B 3.18B 22.01B 8.51B 111B 8.62B 8.43B 354B 1.92B 2.6B 2.23B 2.1B 3.58B 245B 3.6B 24.89B 9.62B 126B 9.75B 9.53B 400B
Net Debt 6.88B 9.31B 8.01B 7.53B 12.86B 881B 12.9B 89.3B 34.52B 451B 34.97B 34.21B 1,437B 6.27B 8.49B 7.3B 6.86B 11.72B 803B 11.76B 81.4B 31.46B 411B 31.87B 31.18B 1,309B
Logo Haleon plc
Haleon plc specializes in the research, manufacture and marketing of drugs and consumer pharmaceutical products. Net sales break down by family of products as follows: - oral health products (31.4%; no. 1 worldwide): Sensodyne, Parodontax, Polident, Biotene, Aquafresh brands, etc.; - pain relief medicines (23.2%; no. 1 worldwide): Panadol, Advil, Voltaren, Excedrin brands, etc.; - respiratory medicines (17%; no. 1 worldwide): Theraflu, Otrivin, Flonase, Contac brands, etc.; - vitamins, minerals and food supplements (15.3%; no. 1 worldwide): Centrum, Emergen-C, Caltrate brands, etc.; - medicines for digestive health (8.9%; no. 1 worldwide): TUMS, Nicorette, ENO, Chap Stick, Fenistil, Nexium brands, etc.; - other (4.2%). Net sales are distributed geographically as follows: Europe/Middle East/Africa/Latin America (41.6%), North America (35.1%), and Asia/Pacific (23.3%).
Employees
24,535
Date Price Change Volume
26-09-08 GBX 343.20 -0.03% 1,763,886
26-09-07 GBX 343.30 -2.69% 23,818,644
26-09-04 GBX 352.80 -1.34% 42,934,648
26-09-03 GBX 357.60 -2.30% 21,137,058
26-09-02 GBX 366.00 -1.05% 23,758,744
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
3.433GBP
Average target price
4.211GBP
Spread / Average Target
+22.67%

Quarterly revenue - Rate of surprise

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!